FDA acting commissioner seeks watchdog review of Alzheimer's drug approval
The acting commissioner of the Food and Drug Administration on Friday asked the Department of Health and Human Services' inspector general to review the agency's approval of a new Alzheimer's drug.
No comments:
Post a Comment
Nigeria News Comments are Moderated.
Clean Comments will be swiftly approved.
No swear words, no racism, allowed